Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children
Article first published online: 28 FEB 2013
© 2013 The Authors. Pediatric Obesity © 2013 International Association for the Study of Obesity
Volume 9, Issue 2, pages 81–91, April 2014
How to Cite
Ooi, S. Q., Chan, R. M. E., Poh, L. K. S., Loke, K. Y., Heng, C. K., Chan, Y. H., Gan, S. U., Lee, K. O. and Lee, Y. S. (2014), Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. Pediatric Obesity, 9: 81–91. doi: 10.1111/j.2047-6310.2013.00149.x
- Issue published online: 11 MAR 2014
- Article first published online: 28 FEB 2013
- Manuscript Accepted: 10 JAN 2013
- Manuscript Revised: 28 DEC 2012
- Manuscript Received: 2 JUN 2012
- National Medical Research Council (NMRC)
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!